POC Hematology and Flow Cytometry Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023

This new 238-page report contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
 
Market Segmentation Analysis

- Review of nine POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

-  Five-year test volume and reagent sales forecasts for hematology and flow cytometry
   procedures by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Operating/Recovery Suites      
- ICUs/CCUs 
- Cancer Clinics        
- Ambulatory Care Centers        
- Surgery Centers 
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis

-  Sales and market shares of major hematology and flow cytometry
    reagent and instrument suppliers.

Instrument Placements and Installed Base

-  The report provides estimates of annual placements and total installed base
    for major hematology  and flow cytometry analyzers.

Current and Emerging Products

- Analysis of hematology and flow cytometry procedures performed in POC testing locations.

- Review of leading hematology and flow cytometry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing
   hematology and flow cytometry  testing technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new hematology and flow cytometry instruments and reagent  systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and the proprietary data files.



Introduction
Executive Summary
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Major Routine and Special Hematology Tests
1. CBC Analysis
a. Hemoglobin Concentration
b. Hematocrit Determination
c. Red Blood Cell Count
d. Platelets
Instrumentation: Hematology Analyzers Manufactured by:
- Abbott
- Becton Dickinson
- Beckman Coulter/Danaher
- Biocode
- Drew-Scientific
- Diesse Ves Matic
- Horiba
- Menarini
- Nihon Kohden
- Polymedco
- Sysmex

Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
? Overview
? ELISA
? Dot Immunobinding Assays
? Capillary Immunoassays
? Particle-Membrane Capture Immunoassay
? Enzyme Amplification
c. Fluorescent Immunoassays
? Fluorescent Polarization
? Time-Resolved Pulse Fluorescence
d. Luminescence
? Chemiluminescence
? Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
? Polymerase Chain Reaction
? Ligase Chain Reaction
? Branched DNA
? Q-Beta Replicase
? Strand Displacement Activation
? Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement

d. Industry Consolidation
e. Managed Care
? PPO
? HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
? More Chronic Illness
? Disease Incidence
? Susceptibility to latrogenesis
? Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments
a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
a. Market Summary
b. Test Volume and Sales Forecasts
D. Cancer Clinics
1. Introduction
2. Market Summary
3. Test Volume and Sales Forecasts

E. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
F. Surgery Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
G. Nursing Homes
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
H. Birth Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
I. Major Suppliers Instrument Placements,
Installed Base, Instrument and Consumables Sales, and Market Shares
Major Product Development Opportunities
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Iris Diagnostics/Danaher
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens
- Sysmex

List Of Tables


U.S.A., Physician Office/Group Practice
Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices
Forecast by Type
U.S.A., Office-Based Physicians
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Routine Hematology Test Volume Forecast
U.S.A., Physician Offices Laboratories
Flow Cytometry and Special Hematology
Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Hematology and Flow Cytometry Test Volume
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Hematology and Flow Cytometry Consumables
Market Forecast

U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments
Routine Hematology Test Volume Forecast

U.S.A., Hospital Emergency Departments
Hematology Reagent Market Forecast
U.S.A., Hospital Operating and Recovery Suites
Routine Hematology Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites
Hematology Reagent Market Forecast
U.S.A., Hospital ICUs/CCUs
Routine Hemagology Test Volume Forecast

U.S.A., Hospital ICUs/CCUs
Hematology Reagent Market Forecast
U.S.A., Cancer Clinics Routine
Hematology/Flow Cytometry Test Volume Forecast
U.S.A., Cancer Clinics Hematology
and Flow Cytometry Reagent Market Forecast
U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers
Routine Hematology Test Volume Forecast
U.S.A., Ambulatory Care Centers
Hematology Reagent Market Forecast
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers
Routine Hematology Test Volume Forecast
U.S.A., Surgery Centers Hematology
Consumable Market Forecast
U.S.A., Nursing Homes
Estimated Number of Facilities,
Beds and Occupancy Rate
U.S.A., Nursing Homes
Routine Hematology Test Volume Forecast

U.S.A., Nursing Homes
Hematology Reagent Market Forecast


U.S.A., Birth Centers Facilities,
Patient Visits, and Births
U.S.A., Birth Centers
Routine Hematology Test Volume Forecast
U.S.A., Birth Centers
Hematology Reagent Market Forecast
U.S.A., Hematology Analyzers
Estimated Placements and Installed Base
U.S.A., Flow Cytometers
Estimated Placements and Installed Base
U.S.A., Hematology Diagnostics Market
Estimated Market Shares of Major Suppliers
U.S.A., Hematology Instrument Market
Estimated Market Shares of Major Suppliers
U.S.A., Hematology Consumable Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Diagnostics Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Consumable Market
Estimated Market Shares of Major Suppliers
U.S.A., Flow Cytometry Instruments Market
Estimated Market Shares of Major Suppliers

Clinical Chemistry Laboratory and POC Instrumentation, 2019: Immunodiagnostic Analyzers and Strategic Profiles of Leading Suppliers

This 68-page report reviews operating characteristics and features of high-, medium-, and low-volume/POC clinical chemistry and immunodiagnostic systems. The report also presents strategic assessments of current and emerging suppliers of

USD 2450 View Report

Hemostasis Laboratory and POC Testing Instrumentation, 2019: Coagulation Analyzers and Strategic Profiles of Leading Suppliers

This 71-page report reviews current instrumentation technologies, and compares features of leading automated and semiautomated analyzers.The report also presents strategic assessments of current and emerging suppliers of coagulation products, including

USD 2450 View Report

Switzerland Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

USD 2450 View Report

Sweden Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

USD 2450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available